Vol. 8 No. 2 (2005)
Editorial

Impacting the Practice of Medicine by Industry

Published 2020-12-01

Keywords

  • Medical practice,
  • Industry

How to Cite

1.
Lin S. Impacting the Practice of Medicine by Industry. McGill J Med [Internet]. 2020 Dec. 1 [cited 2025 Oct. 7];8(2). Available from: https://mjm.mcgill.ca/article/view/666

Abstract

N/A

Downloads

Download data is not yet available.

References

  1. Conrad P, Leiter V. Medicalization, markets and consumers. J Health Soc Behav 45 Suppl:158-76; 2004.
  2. Food and Drug Administration, Center for Drug Evaluation and Research. Guidance for Industry. Available at: http://www.fda.gov/cder/guidance/1804fnl.htm. Accessibility verified June 1, 2005.
  3. Rosenthal MB, Berndt ER, Donohue JM, et al. Promotion of prescription drugs to consumers. N Engl J Med 346(7):498-505; 2002.
  4. The Washington Post. Drug Ads Hyping Anxiety Make Some Uneasy. Available at: http://www.washingtonpost.com/ac2/wpdyn?pagename=article&node=&contentId=A1208-2001Jul15. Accessibility verified June 1, 2005.
  5. Lipsky MS, Taylor CA. The Opinions and Experiences of Family Physicians Regarding Direct-to-Consumer Advertising. J Fam Pract 45(6):495-9; 1997.
  6. Kuehn BM. Pharmaceutical industry funding for residencies sparks controversy. JAMA 293(13):1572-80; 2005.